HK1047885A1 - 肌氨酸或者肌氨酸化合物作为皮肤护理的用途 - Google Patents

肌氨酸或者肌氨酸化合物作为皮肤护理的用途 Download PDF

Info

Publication number
HK1047885A1
HK1047885A1 HK02107744.2A HK02107744A HK1047885A1 HK 1047885 A1 HK1047885 A1 HK 1047885A1 HK 02107744 A HK02107744 A HK 02107744A HK 1047885 A1 HK1047885 A1 HK 1047885A1
Authority
HK
Hong Kong
Prior art keywords
creatine
compounds
skin preservation
salt
subject
Prior art date
Application number
HK02107744.2A
Other languages
English (en)
Chinese (zh)
Inventor
Kaddurah-Daouk Rima
Original Assignee
Enerdermics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enerdermics, Inc. filed Critical Enerdermics, Inc.
Publication of HK1047885A1 publication Critical patent/HK1047885A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
HK02107744.2A 1999-06-25 2000-06-23 肌氨酸或者肌氨酸化合物作为皮肤护理的用途 HK1047885A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/344,427 US6242491B1 (en) 1999-06-25 1999-06-25 Use of creatine or creatine compounds for skin preservation
US09/344,427 1999-06-25
PCT/US2000/017313 WO2001000203A1 (en) 1999-06-25 2000-06-23 Use of creatine or creatine compounds for skin preservation

Publications (1)

Publication Number Publication Date
HK1047885A1 true HK1047885A1 (zh) 2003-03-14

Family

ID=23350508

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107744.2A HK1047885A1 (zh) 1999-06-25 2000-06-23 肌氨酸或者肌氨酸化合物作为皮肤护理的用途

Country Status (7)

Country Link
US (14) US6242491B1 (https=)
EP (2) EP1198230A4 (https=)
JP (3) JP2003503348A (https=)
AU (2) AU783758B2 (https=)
CA (1) CA2376943C (https=)
HK (1) HK1047885A1 (https=)
WO (1) WO2001000203A1 (https=)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE332127T1 (de) * 1994-11-08 2006-07-15 Avicena Group Inc Verwendung von kreatin oder kreatinanologen zur behandlung von huntington chorea, morbus parkinson und amyotrophen lateralsklerose
WO1999051097A1 (en) * 1998-04-02 1999-10-14 Avicena Group, Inc. Compositions containing a combination of a creatine compound and a second agent
US20060128671A1 (en) * 1998-04-02 2006-06-15 The General Hospital Corporation Compositions containing a combination of a creatine compound and a second agent
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
US7713569B2 (en) * 2000-09-01 2010-05-11 Creagri, Inc. Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof
US9833427B2 (en) 2000-09-14 2017-12-05 Board Of Regents Of The University Of Nebraska Creatine ester anti-inflammatory compounds and formulations
US20030212130A1 (en) * 2000-09-14 2003-11-13 Miller Donald W. Creatine ester anti-inflammatory compounds and formulations
US20030212136A1 (en) * 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
US8557868B2 (en) 2000-11-04 2013-10-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions using low molecular weight amines
US6413552B1 (en) * 2000-11-27 2002-07-02 David M. Stoll Topically applied creatine containing composition
DE10106288A1 (de) * 2001-02-02 2002-09-05 Coty Bv Revitalisierender Wirkkomplex für die Haut
DE10114561A1 (de) * 2001-03-24 2002-09-26 Wella Ag Verwendung von Mitteln enthaltend Kreatin, Kreatin und/oder deren Derivaten zur Verstärkung und Strukturverbesserung von keratinischen Fasern
DE10133198A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Kreatin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
DE10136077A1 (de) * 2001-07-25 2003-02-13 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin und/oder Kreatininderivaten mit Kreatin und/oder seinen Derivaten
DE10159244A1 (de) * 2001-12-03 2003-06-18 Degussa Bioactives Deutschland Feste und stabile Kreatin/Citronensäure-Zusammensetzung(en) und Kohlenhydrat(e) bzw. deren Hydrate enthaltende Formulierung, Verfahren zu ihrer Herstellung und deren Verwendung
DE10205190B4 (de) * 2002-02-08 2017-06-08 Beiersdorf Ag 2-Methyl-1,3-propandiol haltige Zubereitungen
US20030167556A1 (en) * 2002-03-05 2003-09-11 Consumers Choice Systems, Inc. Methods and devices for transdermal delivery of anti-aging compounds for treatment and prevention of facial or neck skin aging
DE10215007A1 (de) * 2002-04-05 2003-10-16 Degussa Bioactives Deutschland Verwendung von Kreatinpyruvat zur Steigerung der Ausdauer bei hochintensiven körperlichen Intervallbelastungen
EP1567180A4 (en) * 2002-06-04 2010-03-10 Avicena Group Inc METHOD FOR THE TREATMENT OF COGNITIVE DYSFUNCTION BY MODULATING THE CHANGE OF ENERGY REPLACEMENT IN THE BRAIN
US20030235571A1 (en) * 2002-06-19 2003-12-25 Gabriel Gojon-Romanillos Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
US8361514B2 (en) * 2002-06-19 2013-01-29 Nuevas Alternatives Naturales Thermafat, S.A.P.I. de C.V. Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
EP1583546B1 (en) * 2002-10-25 2019-06-19 Precision Dermatology, Inc. Modulation of zinc levels to improve tissue properties
DE10300782A1 (de) * 2003-01-11 2004-07-22 Beiersdorf Ag Hautpflegeprodukte mit labilen Wirkstoffen in multiplen Emulsionen
DE10301632A1 (de) * 2003-01-17 2004-07-29 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Kreatin, Kreatinin und/oder seinen Derivaten in Kombination mit Sojabohnenkeimextrakten
AU2004218468B2 (en) * 2003-02-28 2007-04-19 E-L Management Corp. Method for increasing hair growth
DE10316666B4 (de) * 2003-04-10 2015-04-09 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin mit Kreatin und Coenzym Q10
DE10355715A1 (de) * 2003-11-26 2005-06-16 Beiersdorf Ag Wirkstoffkombinationen Kreatin und/oder Kreatinderivaten und/oder Kreatinin und/oder Kreatininderivaten und einer wirksamen Menge an Retinoiden, insbesondere Retinol bzw. Retinylpalmitat und Zubereitungen, solche Wirkstoffkombinationen enthaltend
DE10355714A1 (de) * 2003-11-26 2005-06-30 Beiersdorf Ag Wirkstoffkombination aus Kreatin und/oder Kreatinin, Phenoxyethanol und gewünschtenfalls Glycerin
DE10355716A1 (de) * 2003-11-26 2005-06-23 Beiersdorf Ag Kosmetische Zubereitungen mit einem Gehalt Kreatin und/oder Kreatinderivaten und/oder Kreatinin und/oderKreatininderivaten und organischen Verdickern
KR101395370B1 (ko) 2004-01-22 2014-05-14 유니버시티 오브 마이애미 국소용 코-엔자임 큐10 제형 및 그의 사용 방법
FR2865398B1 (fr) * 2004-01-23 2009-07-03 Jean Noel Thorel Compositions destinees a la protection cellulaire vis-a-vis des uva, de la peau, et/ou des phaneres.
US20050197321A1 (en) * 2004-03-04 2005-09-08 Riggs Robert S. Treatment of sepsis
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
WO2006092449A2 (en) * 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
DE102005009990A1 (de) * 2005-03-04 2006-09-07 Degussa Ag Salze, Anlagerungs- und Komplexverbindungen der Guanidinoessigsäure
US8536222B2 (en) 2005-03-04 2013-09-17 Alzchem Ag Addition compounds of guanidinoacetic acid
FR2887452B3 (fr) * 2005-06-22 2007-09-07 Jean Noel Thorel Compositions cosmetiques destinees a la prevention et au traitement des rides
CN101296684B (zh) * 2005-08-25 2012-10-10 高露洁-棕榄公司 保湿组合物
WO2007034750A1 (ja) * 2005-09-22 2007-03-29 Shiseido Company, Ltd. しわ改善剤
US20070265221A1 (en) * 2006-05-09 2007-11-15 Weiss Robert G Methods to improve creatine kinase metabolism and contractile function in cardiac muscle for the treatment of heart failure
AU2007249847A1 (en) * 2006-05-11 2007-11-22 Avicena Group, Inc. Methods of treating a neurological disorder with creatine monohydrate
WO2007133731A2 (en) * 2006-05-11 2007-11-22 Avicena Group, Inc. Creatine-ligand compounds and methods of use thereof
DE102006050931A1 (de) * 2006-10-28 2008-04-30 Alzchem Trostberg Gmbh Feste oder wässrige alkalische Zubereitung auf Basis einer Kreatin-Komponente, Verfahren zu deren Herstellung und ihre Verwendung
US20080206170A1 (en) * 2006-12-07 2008-08-28 Belinda Tsao Nivaggioli Creatine compositions for skin treatment
DE102007004781A1 (de) * 2007-01-31 2008-08-07 Alzchem Trostberg Gmbh Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels
US20090197819A1 (en) * 2007-03-20 2009-08-06 Clarence Albert Johnson Compositions for improving and repairing skin
US20080312169A1 (en) * 2007-03-20 2008-12-18 Clarence Albert Johnson Cosmetic use of D-ribose
WO2008137137A1 (en) * 2007-05-03 2008-11-13 Avicena Group, Inc. Creatine ascorbyl derivatives and methods of use thereof
EP2162126A4 (en) * 2007-06-05 2013-08-28 Cryxa Llc MAGENTATE-RESISTANT COATED SOLUBLE CREATINE AND POLYETHYLENE GLYCOL COMPOSITION TO IMPROVE THE BONE RECEPTACY OF ORAL CREATINE
US20090105196A1 (en) * 2007-06-22 2009-04-23 Belinda Tsao Nivaggioli Use of creatine compounds to treat dermatitis
US20090232750A1 (en) * 2008-03-13 2009-09-17 St Cyr John A Compositions for indoor tanning
MX2010011032A (es) 2008-04-11 2011-03-01 Cytotech Labs Llc Star Metodos y uso de induccion de apoptosis en celulas cancerigenas.
WO2010074591A1 (ru) 2008-12-24 2010-07-01 Закрытое Акционерное Общество "Beptekc" Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием
ES2615204T3 (es) 2009-04-06 2017-06-05 Crearene Ltd. Soluciones para la hemodiálisis y diálisis peritoneal que comprenden uno o más compuestos de creatina
US20120128654A1 (en) * 2009-04-23 2012-05-24 University Of Cincinnati Allantoin Administration for the Treatment of Neurodegenerative Disease and Neurotrauma
CN102481271A (zh) 2009-05-11 2012-05-30 博格生物系统有限责任公司 利用表观代谢转变剂、多维细胞内分子或环境影响剂治疗代谢障碍的方法
RU2428414C2 (ru) 2009-11-03 2011-09-10 Закрытое Акционерное Общество "Вертекс" Способ получения амидов креатина
AU2011227202A1 (en) * 2010-03-17 2012-10-04 Arbonne International Llc Oral supplement
CA2832324C (en) 2011-04-04 2022-03-15 Berg Llc Methods of treating central nervous system tumors
WO2013043580A2 (en) 2011-09-19 2013-03-28 Gencia Corporation Modified creatine compounds
US9233099B2 (en) 2012-01-11 2016-01-12 University Of Cincinnati Methods of treating cognitive dysfunction by modulating brain energy metabolism
ES2590708T3 (es) 2012-07-30 2016-11-23 Commissariat à l'énergie atomique et aux énergies alternatives Método para preparar ésteres grasos de creatina, ésteres grasos de creatina preparados de este modo y usos de los mismos
NZ713868A (en) 2013-04-08 2021-12-24 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
TW201532621A (zh) * 2013-04-22 2015-09-01 Neocutis Sa 抗氧化劑組成物及其使用方法
KR102370843B1 (ko) 2013-09-04 2022-03-04 버그 엘엘씨 코엔자임 q10의 연속주입에 의한 암치료 방법
US20170056352A1 (en) 2015-08-25 2017-03-02 Rgenix, Inc. PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
WO2017087034A1 (en) * 2015-11-19 2017-05-26 Avon Products, Inc. Peptides and their use in the treatment of hair
WO2018160178A1 (en) 2017-03-01 2018-09-07 Rgenix, Inc. Pharmaceutically acceptable salts of b-guanidinopropionic acid with improved properties and uses thereof
EP3563830A1 (en) 2018-05-03 2019-11-06 Commissariat à l'énergie atomique et aux énergies alternatives Micro-emulsion containing creatine fatty ester, method for preparing said micro-emulsion and uses thereof
EP3732995A1 (en) 2019-04-30 2020-11-04 Commissariat à l'énergie atomique et aux énergies alternatives Composition containing creatine fatty ester for use in medicine
EP4072561A4 (en) 2019-12-11 2023-11-29 Inspirna, Inc. CANCER TREATMENT METHODS

Family Cites Families (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB817749A (en) 1949-07-18 1959-08-06 Mini Of Supply Preparation of substituted guanidines
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US4017641A (en) 1975-01-31 1977-04-12 The Procter & Gamble Company Skin moisturizing compositions containing 2-pyrrolidinone
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
GB1541463A (en) 1975-10-11 1979-02-28 Lion Dentifrice Co Ltd Process for prparing a multiple emulsion having a dispersing form of water-phase/oil-phase/water-phase
US4130667A (en) 1976-01-12 1978-12-19 The Procter & Gamble Company Dermatological compositions
US4308257A (en) * 1980-06-03 1981-12-29 Saul Caspe Accelerating cellular repair composition for the human body and method of administering same
CA1165240A (en) 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
FR2509724B1 (fr) 1981-07-15 1985-10-25 Centre Nat Rech Scient Nouvelles guanidines a fort encombrement sterique et procedes pour leur preparation
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US4537776A (en) 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
US4552872A (en) 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
GB8401206D0 (en) 1984-01-17 1984-02-22 Allied Colloids Ltd Polymers and aqueous solutions
GB8414950D0 (en) 1984-06-12 1984-07-18 Allied Colloids Ltd Cationic polyelectrolytes
US4663157A (en) 1985-02-28 1987-05-05 The Proctor & Gamble Company Sunscreen compositions
US4772591A (en) 1985-09-25 1988-09-20 Peritain, Ltd. Method for accelerated wound healing
US5385938B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
US5702688A (en) * 1986-12-23 1997-12-30 Tristrata Technology, Inc. Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
US5091171B2 (en) 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US4960764A (en) 1987-03-06 1990-10-02 Richardson-Vicks Inc. Oil-in-water-in-silicone emulsion compositions
US4912248A (en) 1987-05-18 1990-03-27 The Procter & Gamble Company Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation
US4847069A (en) 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent
US4847071A (en) 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US4891227A (en) 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
US4891228A (en) 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
US4839159A (en) * 1988-02-08 1989-06-13 Topicarn, Inc. Topical L-carnitine composition
US5324731A (en) 1989-02-14 1994-06-28 Amira, Inc. Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated
US5676978A (en) 1989-02-14 1997-10-14 Amira, Inc. Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent
EP0458901B1 (en) 1989-02-14 1997-12-17 Massachusetts Institute Of Technology Inhibiting transformation of cells having elevated purine metabolic enzyme activity
US5321030A (en) * 1989-02-14 1994-06-14 Amira, Inc. Creatine analogs having antiviral activity
US5256649A (en) * 1989-05-23 1993-10-26 Elf Sanofi Cosmetic composition against aging of the skin
US5599841A (en) * 1990-02-28 1997-02-04 The Upjohn Company Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
JPH05301457A (ja) 1990-07-09 1993-11-16 Honshu Paper Co Ltd 感熱記録体
US5091404A (en) 1990-10-05 1992-02-25 Elgebaly Salwa A Method for restoring functionality in muscle tissue
EP0500332B1 (en) 1991-02-19 1998-05-27 National Food Research Institute Ministry Of Agriculture, Forestry And Fisheries Novel acylamino acid compounds and a method for their production
US5404687A (en) 1991-04-24 1995-04-11 Avco Corporation Intumescent fireproofing panel system
US5378461A (en) * 1991-07-12 1995-01-03 Neigut; Stanley J. Composition for the topical treatment of skin damage
EP0529130A1 (en) 1991-08-28 1993-03-03 International Business Machines Corporation Expert system with explanation system
US5266318A (en) * 1991-12-09 1993-11-30 Royale Renaissance, Inc. Skin therapeutic mixture containing cold-processsed aloe vera extract, with yellow sap and aloin removed
IT1258069B (it) 1992-04-10 1996-02-20 Composizione per uso topico avente attivita' di stimolo per la ricrescita, di rinvigorimento, di prevenzione dell'ingrigimento e di ripigmentazione naturale dei capelli
US5605687A (en) * 1992-05-15 1997-02-25 Arch Development Corporation Methods and compositions of a polymer (poloxamer) for repair of electrical injury
JPH06192085A (ja) * 1992-08-31 1994-07-12 Yuji Inada ダニアレルギー治療剤
US5674703A (en) 1992-12-02 1997-10-07 Woo; Savio L. C. Episomal vector systems and related methods
WO1994016687A1 (en) 1993-01-28 1994-08-04 The Trustees Of The University Of Pennsylvania Use of creatine or analogs for the manufacture of a medicament for inhibiting tumor growth
IT1261688B (it) * 1993-05-28 1996-05-29 Avantgarde Spa Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
US5627172A (en) * 1994-03-04 1997-05-06 Natural Supplement Association, Incorporated Method for reduction of serum blood lipids or lipoprotein fraction
DE4410238A1 (de) 1994-03-25 1995-09-28 Beiersdorf Ag Hautpflegemittel
US5441740A (en) * 1994-05-06 1995-08-15 Longevity Network. Ltd. Cosmetic composition containing alpha hydroxyacids, salicyclic acid, and enzyme mixture of bromelain and papain
TW300883B (https=) * 1994-07-26 1997-03-21 Kao Corp
IT1274157B (it) * 1994-09-08 1997-07-15 Avantgarde Spa "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
FR2725896B1 (fr) * 1994-10-19 1996-11-29 Sederma Sa Nouvelles compositions cosmetiques ou dermopharmaceutiques
ATE332127T1 (de) 1994-11-08 2006-07-15 Avicena Group Inc Verwendung von kreatin oder kreatinanologen zur behandlung von huntington chorea, morbus parkinson und amyotrophen lateralsklerose
DE19537027A1 (de) * 1995-10-05 1997-04-10 Beiersdorf Ag Hautpflegemittel für alte Haut
EP0854712B1 (en) * 1995-10-11 2003-05-07 Avicena Group, Inc. Use of creatine analogues for the treatment of disorders of glucose metabolism
FR2740681B1 (fr) 1995-11-07 1998-01-23 Fabre Pierre Dermo Cosmetique Composition cosmetique a base d'un extrait de viburnum
JPH09202710A (ja) * 1995-11-20 1997-08-05 Kao Corp しわ改善剤
US5939078A (en) 1995-11-20 1999-08-17 Kao Corporation Wrinkle-care product
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
US5834513A (en) * 1996-04-25 1998-11-10 Avon Products, Inc. Oxa diacids and related compounds for treating skin conditions
AU6486096A (en) 1996-05-08 1997-11-26 Government Of The United States Of America As Represented By The Secretary Of The Army Pharmaceutical compositions containing alpha-keto carboxylates
JP3240580B2 (ja) 1996-05-14 2001-12-17 エイボン プロダクツ インコーポレイテッド アスコルビル−ホスホリル−コレステロール
JPH1053516A (ja) * 1996-05-20 1998-02-24 Shiseido Co Ltd 抗老化皮膚外用剤及びコラーゲン架橋防止用皮膚外用剤
US6168802B1 (en) * 1996-05-31 2001-01-02 The Howard Foundation Compositions containing creatine and aloe vera extract
US6524611B2 (en) * 1996-05-31 2003-02-25 The Howard Foundation Compositions containing creatine and creatinine
US5847003A (en) 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
US6338855B1 (en) * 1996-10-25 2002-01-15 The Procter & Gamble Company Cleansing articles for skin and/or hair which also deposit skin care actives
NZ332830A (en) * 1996-12-20 2000-04-28 Sueddeutsche Kalkstickstoff Creatine pyruvates, method for their production and their use in medicaments for weight control, body fat control, increasing muscle strength, the treatment of oxygen deficiency conditions and as free radical scavengers
DE19653225A1 (de) * 1996-12-20 1998-06-25 Sueddeutsche Kalkstickstoff Kreatin-pyruvate und Verfahren zu deren Herstellung
DE19707694A1 (de) * 1997-02-26 1998-08-27 Sueddeutsche Kalkstickstoff Kreatin-ascorbate und Verfahren zu deren Herstellung
DE852949T1 (de) 1997-03-31 1998-11-19 Shiseido Co Ltd Verwendung von Alpha-Aminosäuren zur Förderung des desmosomalen Abbaues oder der Abschuppung der Hornschicht
US5925378A (en) * 1997-03-31 1999-07-20 Fortress Systems, L.L.C. Method for enhancing delivery and uniformity of concentration of cellular creatine
US5773473A (en) * 1997-04-15 1998-06-30 Green; Jerold L. Creatine supplement
US6001377A (en) * 1997-05-23 1999-12-14 The Procter & Gamble Company Skin care compositions and method of improving skin appearance
US5886040A (en) * 1997-06-17 1999-03-23 Amt Labs, Inc. Creatine pyruvate salt with enhanced palatability
US6465018B1 (en) * 1997-08-22 2002-10-15 B. David Tuttle Dietary supplement for increasing energy, strength, and immune function
US6193973B1 (en) * 1997-08-22 2001-02-27 B. David Tuttle Dietary supplement for boosting energy and increasing muscular strength
DE19743547B4 (de) * 1997-10-01 2005-12-22 Siemens Ag Verfahren zur Abbildung von Fett-Plaques mittels Kernspintomographie
US5994581A (en) * 1998-03-09 1999-11-30 Amt Labs, Inc. Carnitine creatinate
JP2002512944A (ja) 1998-04-24 2002-05-08 ザ、プロクター、エンド、ギャンブル、カンパニー スキンケア活性剤が沈着する皮膚及び／又は毛髪のための洗浄剤物品
AU744295B2 (en) 1998-04-27 2002-02-21 Color Access, Inc. Composition and method for treatment of aging skin
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
PT1100488E (pt) * 1998-07-28 2003-09-30 Synthes Ag Utilizacao de compostos de creatina para tratamento das celulas e tecidos do osso ou cartilagem
DE19841385A1 (de) 1998-09-10 2000-03-16 Sueddeutsche Kalkstickstoff Verwendung von Kreatin und/oder Kreatin-derivaten als Feuchthaltemittel in kosmetischen Zubereitungen
JP3923226B2 (ja) * 1998-12-28 2007-05-30 ライオン株式会社 皮膚外用剤
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
US6630163B1 (en) * 1999-04-22 2003-10-07 Howard Murad Method of treating dermatological disorders with fruit extracts
US6277881B1 (en) * 1999-05-27 2001-08-21 Unilever Home & Personal Care, Usa, Division Of Conopco, Inc. Turmeric as an anti-irritant in compositions containing hydroxy acids or retinoids
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US6335023B1 (en) 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
AU7828200A (en) * 1999-09-23 2001-04-24 Juvenon Corporation Nutritional supplement for increased energy and stamina
JP2001114701A (ja) 1999-10-12 2001-04-24 Lion Corp 皮膚外用剤
US20020044913A1 (en) * 2000-02-11 2002-04-18 Hamilton Nathan D. Cosmetics to support skin metabolism
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
US6413552B1 (en) * 2000-11-27 2002-07-02 David M. Stoll Topically applied creatine containing composition
DE10106288A1 (de) 2001-02-02 2002-09-05 Coty Bv Revitalisierender Wirkkomplex für die Haut
DE10133198A1 (de) 2001-07-07 2003-01-23 Beiersdorf Ag Kreatin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
DE10133200A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Carnitin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
DE10136077A1 (de) * 2001-07-25 2003-02-13 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin und/oder Kreatininderivaten mit Kreatin und/oder seinen Derivaten
US20040228884A1 (en) * 2003-05-15 2004-11-18 Gupta Shyam K. Ion-pair delivery system for cosmetic and pharmaceutical compositions
US20040092482A1 (en) * 2002-11-07 2004-05-13 Gupta Shyam K. Hydroxy acids based delivery systems for skin resurfacing and anti-aging compositions
US20040161435A1 (en) * 2003-02-14 2004-08-19 Gupta Shyam K. Skin Firming Anti-Aging Cosmetic Mask Compositions
US20040208902A1 (en) * 2003-04-18 2004-10-21 Gupta Shyam K. Controlled-release nano-diffusion delivery systems for cosmetic and pharmaceutical compositions
US20040219124A1 (en) * 2003-05-01 2004-11-04 Gupta Shyam K. Cosmetic and Pharmaceutical Masks Based on Ion-Pair Delivery System

Also Published As

Publication number Publication date
US20050227996A1 (en) 2005-10-13
JP2012012409A (ja) 2012-01-19
JP2014240406A (ja) 2014-12-25
US20110085993A1 (en) 2011-04-14
JP2003503348A (ja) 2003-01-28
US20110008272A1 (en) 2011-01-13
US6242491B1 (en) 2001-06-05
US20100329997A1 (en) 2010-12-30
WO2001000203A1 (en) 2001-01-04
AU5761600A (en) 2001-01-31
US20070253944A1 (en) 2007-11-01
US20020049253A1 (en) 2002-04-25
EP1198230A4 (en) 2004-06-16
EP2397127A1 (en) 2011-12-21
CA2376943C (en) 2010-09-21
CA2376943A1 (en) 2001-01-04
US20050186194A1 (en) 2005-08-25
US20050186158A1 (en) 2005-08-25
US20100226870A1 (en) 2010-09-09
AU2009236026A1 (en) 2009-12-03
US20050186195A1 (en) 2005-08-25
US20110021632A1 (en) 2011-01-27
US7186754B2 (en) 2007-03-06
US20050226840A1 (en) 2005-10-13
EP1198230A1 (en) 2002-04-24
AU783758B2 (en) 2005-12-01
US20120141391A1 (en) 2012-06-07

Similar Documents

Publication Publication Date Title
HK1047885A1 (zh) 肌氨酸或者肌氨酸化合物作为皮肤护理的用途
ATE332687T1 (de) Liponsäure in topischen mittel
WO2005047244A3 (en) Inhibition of fgfr3 and treatment of multiple myeloma
EP0059428A3 (en) Hair treatments
ATE273049T1 (de) Enthaarungsverfahren
WO2004006906A3 (en) Methods for the treatment of neoplasms
MXPA05009694A (es) Metodos para mejorar la calidad de la piel.
CZ129295A3 (en) Microbicide for plant protection and its application
DE602004003587D1 (de) Kosmetische verwendung einer zusammensetzung mit mindestens einem oxazolin als wirkstoff, als abnehmprodukt und/oder zur prävention und/oder behandlung von cellulite
CA2315849A1 (en) Quaternary ammonium and waterproofing/preservative compositions
BR0011225A (pt) Agente para tratar de olhos secos, seu método e uso
CA2134347A1 (en) Thiazole or imidazole derivatives as maillard reaction inhibitors
RU94044453A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования себореи и угрей
AR004170A1 (es) Peptidos ciclicos semisinteticos, utiles como inhibidores de hongos y parasitos; procedimiento para prepararlos, formulaciones que los incluyeny metodo para tratar infecciones fungicas con aplicacion de dichas formulaciones
ZA98800B (en) Composition and method for treating plants with exogenous chemicals
WO2004110151A8 (en) Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
GR940100307A (en) Method for treating seeds using phosphoric acid or one of its salts.
GR3031917T3 (en) Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
WO1998036730A3 (de) Zubereitungen für die behandlung von rosacea
AR024811A1 (es) Un metodo de diagnostico para el cuero cabelludo
CA2270469A1 (en) Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
WO2001010427A3 (en) Use of anti-muscarinic agents for treating skin disorders
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.